IL157726A0 - Soluble heterodimeric cytokine receptor - Google Patents
Soluble heterodimeric cytokine receptorInfo
- Publication number
- IL157726A0 IL157726A0 IL15772602A IL15772602A IL157726A0 IL 157726 A0 IL157726 A0 IL 157726A0 IL 15772602 A IL15772602 A IL 15772602A IL 15772602 A IL15772602 A IL 15772602A IL 157726 A0 IL157726 A0 IL 157726A0
- Authority
- IL
- Israel
- Prior art keywords
- cytokine receptor
- heterodimeric cytokine
- soluble heterodimeric
- immunoglobulin
- subunit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27456001P | 2001-03-09 | 2001-03-09 | |
| US29986501P | 2001-06-21 | 2001-06-21 | |
| PCT/US2002/007214 WO2002072607A2 (en) | 2001-03-09 | 2002-03-07 | Soluble heterodimeric cytokine receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL157726A0 true IL157726A0 (en) | 2004-03-28 |
Family
ID=26956904
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15772602A IL157726A0 (en) | 2001-03-09 | 2002-03-07 | Soluble heterodimeric cytokine receptor |
| IL204299A IL204299A (en) | 2001-03-09 | 2010-03-04 | Il-20 antagonist and medicament containing it |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL204299A IL204299A (en) | 2001-03-09 | 2010-03-04 | Il-20 antagonist and medicament containing it |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1399472B1 (es) |
| JP (1) | JP4009535B2 (es) |
| AT (1) | ATE432942T1 (es) |
| AU (1) | AU2002245652A1 (es) |
| CA (1) | CA2440596C (es) |
| DE (1) | DE60232511D1 (es) |
| DK (1) | DK1399472T3 (es) |
| EA (1) | EA005496B1 (es) |
| ES (1) | ES2327821T3 (es) |
| IL (2) | IL157726A0 (es) |
| WO (1) | WO2002072607A2 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003534773A (ja) | 1999-12-03 | 2003-11-25 | ザイモジェネティクス，インコーポレイティド | ヒトサイトカイン受容体 |
| US6610286B2 (en) | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
| US7122632B2 (en) | 1999-12-23 | 2006-10-17 | Zymogenetics, Inc. | Soluble Interleukin-20 receptor |
| US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
| US20030023033A1 (en) * | 2001-07-26 | 2003-01-30 | Laure Dumoutier | Novel class II cytokine receptors and uses thereof |
| ES2381650T3 (es) | 2000-08-08 | 2012-05-30 | Zymogenetics, Inc. | Receptores de citoquinas Zcytor11 solubles |
| EP1803733B1 (en) | 2000-09-15 | 2010-03-10 | ZymoGenetics, Inc. | Polypeptides comprising the extracellular domains of IL-20RA and/or IL-20RB |
| CA2439961A1 (en) | 2001-03-27 | 2002-10-03 | Zymogenetics, Inc. | Human cytokine receptor |
| AU2012216499B2 (en) * | 2001-10-19 | 2015-05-28 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| ATE384783T1 (de) | 2001-10-19 | 2008-02-15 | Zymogenetics Inc | Dimerisierter wachstumsfaktor sowie materialien und verfahren zu seiner herstellung |
| IL161978A0 (en) | 2001-12-17 | 2005-11-20 | Zymogenetics Inc | Method for treating cervical cancer |
| JP2005523001A (ja) | 2002-02-11 | 2005-08-04 | ザイモジェネティクス，インコーポレイティド | 二量体増殖因子を調製するための材料と方法 |
| CA2480163A1 (en) | 2002-03-22 | 2003-10-09 | Zymogenetics, Inc. | Anti-il-tif antibodies and methods of using in inflammation |
| KR20110091598A (ko) * | 2003-03-24 | 2011-08-11 | 지모제넥틱스, 인코포레이티드 | 항-ｉｌ-22ｒａ 항체 및 결합 파트너 및 염증에 있어서의 사용 방법 |
| EP2087905A2 (en) | 2003-08-08 | 2009-08-12 | Novo Nordisk A/S | Interleukin-20 for treating and diagnosing conditions associated with neovascularisation |
| EP2143733A1 (en) | 2003-11-21 | 2010-01-13 | ZymoGenetics, Inc. | ANTI-IL-20 antibodies and binding partners and methods of using in inflammation |
| PT1812476E (pt) | 2004-10-22 | 2010-11-08 | Zymogenetics Inc | Anticorpos anti-il-22ra e parceiros de ligação e métodos de utilização no tratamento de inflamações |
| AU2006212807A1 (en) | 2005-02-08 | 2006-08-17 | Zymogenetics, Inc. | Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| US20070054360A1 (en) | 2005-05-12 | 2007-03-08 | Zeren Gao | Compositions and methods for modulating immune responses |
| CA2789061A1 (en) | 2010-02-26 | 2011-09-01 | Henrik Parshad | Stable antibody containing compositions |
| CA2800188A1 (en) | 2010-05-28 | 2011-12-01 | Novo Nordisk A/S | Stable multi-dose compositions comprising an antibody and a preservative |
| SI3151921T1 (sl) | 2014-06-06 | 2019-12-31 | Bristol-Myers Squibb Company | Protitelesa proti z glukortikoidom induciranim receptorjem za faktor nekroze tumorja(GITR) in njihova uporaba |
| CN107743586B (zh) | 2015-06-03 | 2021-07-02 | 百时美施贵宝公司 | 用于癌症诊断的抗gitr抗体 |
| GB201514875D0 (en) * | 2015-08-20 | 2015-10-07 | Autolus Ltd | Receptor |
| MX2018006072A (es) | 2015-11-19 | 2018-08-01 | Squibb Bristol Myers Co | Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos. |
| CN110869392A (zh) | 2017-05-16 | 2020-03-06 | 百时美施贵宝公司 | 用抗gitr激动性抗体治疗癌症 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965704A (en) * | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
| AU2222700A (en) * | 1998-12-31 | 2000-07-31 | Millennium Pharmaceuticals, Inc. | Class ii cytokine receptor-like proteins and nucleic acids encoding them |
-
2002
- 2002-03-07 EP EP02713823A patent/EP1399472B1/en not_active Expired - Lifetime
- 2002-03-07 WO PCT/US2002/007214 patent/WO2002072607A2/en active Application Filing
- 2002-03-07 AU AU2002245652A patent/AU2002245652A1/en not_active Abandoned
- 2002-03-07 EA EA200300983A patent/EA005496B1/ru not_active IP Right Cessation
- 2002-03-07 ES ES02713823T patent/ES2327821T3/es not_active Expired - Lifetime
- 2002-03-07 DK DK02713823T patent/DK1399472T3/da active
- 2002-03-07 CA CA2440596A patent/CA2440596C/en not_active Expired - Fee Related
- 2002-03-07 DE DE60232511T patent/DE60232511D1/de not_active Expired - Lifetime
- 2002-03-07 AT AT02713823T patent/ATE432942T1/de active
- 2002-03-07 IL IL15772602A patent/IL157726A0/xx not_active IP Right Cessation
- 2002-03-07 JP JP2002571520A patent/JP4009535B2/ja not_active Expired - Fee Related
-
2010
- 2010-03-04 IL IL204299A patent/IL204299A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1399472B1 (en) | 2009-06-03 |
| WO2002072607A3 (en) | 2004-01-15 |
| AU2002245652A1 (en) | 2002-09-24 |
| JP4009535B2 (ja) | 2007-11-14 |
| CA2440596A1 (en) | 2002-09-19 |
| CA2440596C (en) | 2011-05-24 |
| ATE432942T1 (de) | 2009-06-15 |
| EA005496B1 (ru) | 2005-02-24 |
| EA200300983A1 (ru) | 2004-06-24 |
| EP1399472A2 (en) | 2004-03-24 |
| IL204299A (en) | 2011-06-30 |
| ES2327821T3 (es) | 2009-11-04 |
| DE60232511D1 (de) | 2009-07-16 |
| WO2002072607A2 (en) | 2002-09-19 |
| JP2004536040A (ja) | 2004-12-02 |
| DK1399472T3 (da) | 2009-10-05 |
| EP1399472A4 (en) | 2004-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157726A0 (en) | Soluble heterodimeric cytokine receptor | |
| UA84830C2 (uk) | Розчинний рецептор інтерлейкіну-20 | |
| CY1112787T1 (el) | Πολλαπλομερη του υποδοχεα κυτοκινης ζcytor17 | |
| NO20050685L (no) | NOGO-reseptorantagonister | |
| WO2004020405A3 (en) | Modified transferrin fusion proteins | |
| WO2003004529A3 (en) | Ephrin-tie receptor materials and methods | |
| BR0212256A (pt) | Proteìnas de fusão de transferrina modificadas | |
| WO2004020404A3 (en) | Modified transferin-antibody fusion proteins | |
| DE60333306D1 (de) | Modifizierte transferrin-fusionsproteine mit doppelten transferrin-amino- oder carboxy-terminalen domänen | |
| CY1106594T1 (el) | Αντισωματα εναντι ανθρωπινης il-12 | |
| PL336306A1 (en) | Proteinous fusions of tgf-beta ii type receptor with a constant immunoglobulin area | |
| CY1112840T1 (el) | Πρωτεϊνες συντηξης ταci-ανοσοσφαιρινης | |
| WO2004060295A3 (en) | Methods of inducing and maintaining immune tolerance | |
| IL139419A (en) | Antibodies which cross-react with apo-2l receptor and compositions comprising them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |